luminal B breast carcinoma
luminal B breast carcinoma
Explore linked clinical trials. Standard reference: MONDO:00211152 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, luminal B breast carcinoma, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-10-07 | NCT03875573 | |
| Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas | breast adenocarcinoma, luminal B breast carcinoma | Active, not recruiting | Not stated | 2025-02-03 | NCT06805084 |